"We conclude that there is a lack of efficacy in mild Alzheimer's," says the lead researcher, Lon Schneider, M.D., a professor of psychiatry, neurology, and gerontology at the University of Southern California, in Los Angeles. Health.com: 25 signs and symptoms of Alzheimer's disease People with mild Alzheimer's have impaired short- and long-term memory and typically experience difficulty with tasks such as paying bills, according to the Alzheimer's Association. Patients with mild Alzheimer's who took memantine showed no improvement in mental function and their ability to handle everyday tasks (such as bathing and dressing) compared with those who took placebo, either within any one trial or when all of the data were combined. Health.com: 9 foods that may help save your memory Schneider and his colleagues reanalyzed data from three clinical trials that included 431 patients with mild Alzheimer's disease and 697 with moderate Alzheimer's. Nearly one-fifth of all people with mild Alzheimer's received the drug in 2006, and the rates may be far higher in some hospitals and practices, according to the study, which appears in the journal Archives of Neurology.